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Abstract
Because off-target effects hamper interpretation and validation of RNAi screens, we developed a
bioinformatics method, Genome-wide Enrichment of Seed Sequence matches (GESS), to identify
candidate off-targeted transcripts from direct analysis of primary screening data. GESS identified
a prominent off-targeted transcript in several screens, including MAD2 in a screen for components
of the spindle assembly checkpoint. We demonstrate how incorporation of the results of GESS
analysis can enhance the validation rate in RNAi screens.
RNA interference (RNAi) is a powerful discovery tool, but frequent false positives
complicate analysis of genome-wide RNAi screens1–3. The problem arises because siRNAs
can induce microRNA-like effects, downregulating expression of hundreds of genes
nonspecifically4,5. Strikingly, such effects can occur with as few as 6–7 nucleotides of
sequence complementarity, although effects may become more pronounced with greater
complementarity6. Some transcripts may be particularly susceptible to off-targeting7–9, but
the identification of such transcripts typically occurs only after much effort has been
expended to validate genes of interest. Therefore, new methods are necessary to identify off-
targeted transcripts earlier in the validation process.
We conducted an image-based high-throughput siRNA screen (Supplementary Results 1 and
Supplementary Fig. 1) to identify novel components of the spindle assembly checkpoint
(SAC)10. We determined that off-target effects were pervasive, as we were unable to
validate any novel genes from the primary screen despite identifying known components of
the pathway. To understand the basis of the off-target effect, we tested 34 siRNAs with the
strongest phenotype for their ability to downregulate known components of the SAC, and
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tfound that all 34 siRNAs strongly decreased MAD2 mRNA and protein levels in addition to
their intended target (Supplementary Results 2 and Supplementary Fig. 2). Half of these
siRNAs contained a 7mer seed sequence complementary to the MAD2 3′UTR, indicating
the potential for microRNA-like off-targeting. We tested seven of these seed-match
containing siRNAs, and found that all could downregulate a MAD2 3′UTR reporter
construct (Supplementary Fig. 3). We found that over half of all 324 active siRNAs in the
screen contained a 7mer seed match in the MAD2 3′UTR sequence, whereas only 8% of the
inactive siRNAs contained a seed match. These findings indicate that the majority of active
siRNAs in our SAC screen are likely to produce a phenotype by nonspecifically targeting
the MAD2 transcript.
To identify such potentially devastating off-target effects prior to the validation process, we
developed an approach that utilizes primary screening data to identify transcripts that are
sensitive to off-target effects (Fig. 1). Phenotypic screen data is used to separate the siRNAs
into two groups: “with phenotype” and “without phenotype”. The program then calculates
the seed match frequency (SMF) for active (SMFa) and inactive (SMFi) siRNAs for each
transcript encoded in the genome (Fig. 2). In principle, transcripts that are sensitive to off-
targeting will bias the ratio of SMFa: SMFi (Seed Match Enrichment, or SME) such that it
exceeds one and the statistical significance of this bias relative to other genes in the data set
is determined. We refer to this approach as Genome-wide Enrichment for Seed Sequence
match (GESS) analysis. It can be performed using genome-wide databases of full-length
mRNAs or sub-regions of mRNAs (3′UTRs, 5′UTRs, coding sequence), although we have
only identified off-targeted genes using the 3′UTR database, consistent with known rules of
microRNA-based targeting.
We first evaluated the ability of GESS to identify MAD2 as an off-targeted transcript in our
spindle checkpoint screen. We applied GESS analysis to compare the seed match frequency
of the most active siRNAs that produced a loss of SAC phenotype (n = 49) to the siRNAs
that did not (n = 9,856). We analyzed each of 27,534 3′UTR sequences in the human
genome (Fig. 2a). When using a 7mer seed match from either the antisense or sense strand
seed sequences of an siRNA as a search criterion, we found that the 3′UTR of the MAD2
transcript showed a significant seed match enrichment (SMFa: SMFi) of 8 fold (SMFa =
65.3%; SMFi = 8.2%; P = 4.2×10−23). The only other significantly enriched transcript
represented another MAD2 sequence in the database. A GESS analysis where all siRNA
seed sequences were randomly scrambled showed no statistically significant outliers
(Supplementary Fig. 4).
We determined how the GESS analysis of our SAC screen was affected by the following set
of parameters: i) strength of phenotype; ii) the seed sequence length, iii) the seed match
multiplicity; iv) the source of inactive control siRNAs; and v) seed sequence strand choice
(Supplementary Results 3). Relaxing the phenotype strength led to identification of
additional outliers, yet MAD2 remained the most statistically enriched transcript
(Supplementary Fig. 5). Increasing the stringency of the method by lengthening the seed
from 7 to 8 nucleotides also permitted specific identification of MAD2 (Supplementary Fig.
6). Increasing the seed match multiplicity, which increases stringency by requiring two seed
matches per transcript, failed to identify MAD2 in some cases (Supplementary Fig. 7).
Because most published RNAi screens do not provide the nucleotide sequences of all tested
siRNAs, we developed an alternative method for generating a set of inactive seed sequences,
in which nucleotide 1 of the seed sequences of active siRNAs was changed to its
complement (P1c-seeds), and found that this method could be used as a source of inactive
siRNAs (Supplementary Fig. 8). Finally, considering seed matches from only the siRNA
antisense strand showed better sensitivity but somewhat lower specificity than including
each strand in the analysis (Supplementary Fig. 9).
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tWe next tested whether GESS can identify off-targeted transcripts in other published
screens. A recent screen identified siRNAs that could overcome mitotic arrest induced by a
small-molecule inhibitor of the mitotic kinesin Eg511. Since mitotic arrest induced by this
mechanism is SAC-dependent12, we anticipated that MAD2 could be an off-target in this
screen. In this case, the set of experimentally-determined inactive siRNAs was not
published, so we used P1c-seeds to generate the set of inactive siRNAs. GESS analysis of
this data set, using 7mer seeds and a seed match multiplicity of one, indeed identified the
MAD2 3′UTR as the strongest statistically significant outlier, with an SME value of 3.9 (P
= 3.3×10−18; Fig. 2b). A control analysis where all active and inactive siRNA seed
sequences were randomly scrambled showed no significant outliers (Supplementary Fig.
10).
We tested GESS further on a previously published RNAi screen of 6,000 human genes for
novel components of the TGFβ pathway, which failed to identify any novel components of
the pathway and was plagued by off-target effects9. In that study, the vast majority of active
siRNAs tested (89%; 172 of 193 tested) were experimentally confirmed to reduce mRNA
levels of either the TGFβ Receptor 1 or 2, with the latter being more sensitive. We
performed GESS analysis on the primary data of the screen, using the 391 active siRNAs
and 18,869 inactive siRNAs. Using at least one 7mer seed match as a search criterion, GESS
identified the TGFβ-R2 transcript (represented by two sequences in the database) as the
major outlier in the analysis with SME values of 1.6 (P = 1.9×10−12) and 1.4 (P = 3.9×10−9)
while the TGFβ-R1 transcript (two sequences in the database) showed no significant
enrichment (SME = 0.97, P = 0.664 and SME = 0.99, P = 0.832) (Fig. 2c). A third weak
outlier was identified but there is no evidence that it is involved in the TGFβ pathway. A
control GESS analysis with randomly scrambled seed sequences for all siRNAs showed no
significant outliers (Supplementary Fig. 11). We also investigated the effect of varying
GESS parameters on the outcome of the analysis (Supplementary Results 4 and
Supplementary Fig. 12).
Finally, GESS also identified RAD51 as a potential off-targeted gene in a screen for genes
required for homologous recombination13 and off-targeting of RAD51 was confirmed
experimentally13. To examine whether GESS can help prioritize hits from siRNA screens,
we investigated the consequences of removing siRNAs that contain a seed match against the
RAD51 3′UTR (Fig. 3). The primary screen, followed by pool deconvolution, identified 88
candidate genes using a criterion of at least two of four siRNAs producing the phenotype.
After removing siRNAs that contain a 7mer seed match to RAD51 3′UTR, 63 candidate
genes retained at least two of four active siRNAs. We compared the performance of the
original 88 candidates to the set of 63 “GESS-selected” candidate genes. Three additional
independent siRNAs targeting these 88 genes were tested for their ability to reduce
homologous recombination. In this analysis, 32 of 88 genes scored with at least two of three
additional siRNAs, a confirmation rate of 36%. When the analysis was restricted to the set
of GESS-selected candidates, 32 of 63 candidate genes were positive (51%). None of the 25
candidates eliminated by GESS showed a phenotype with more than one out of three new
siRNAs. When this process was repeated using ten randomly selected genes containing a
3’UTR of similar length, no positive effect on validation rate was observed (Supplementary
Table 1). This analysis indicates the value of taking into account potential off-target
transcripts identified by GESS in prioritizing genes for validation in siRNA screens.
There is no tool other than GESS, to our knowledge, that can systematically examine
screening data to directly identify potential off-targeted transcripts. A previously described
approach to identify off-target effects in screens searches for siRNA seed sequences that are
statistically overrepresented in the set of active siRNAs as compared to inactive
siRNAs7,8,14, but does not identify which transcripts might be targeted. We compared GESS
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tto seed sequence enrichment analysis. For screens in which GESS identified a biologically
confirmed, statistically significant outlier, we attempted to identify 7mer seeds that were
overrepresented in active siRNAs compared to inactive siRNAs (Supplementary Table 2a).
In our SAC screen, we identified 8 such seed sequences (Supplementary Table 2b),
indicative of a potential off-target effect. However, seed sequence enrichment analysis alone
failed to highlight the extent of off-targeting in the screen, as only 35 out of 324 active
siRNAs (11%) contained a seed sequence that was significantly enriched. Furthermore, this
analysis cannot directly identify the MAD2 3′UTR as the relevant off-target in this dataset.
Analysis of the data set from the TGFβ pathway RNAi screen9 identified one 7mer seed
sequence that was significantly enriched among active siRNAs (Supplementary Table 2c),
present in only five of 391 (1.28%) active siRNAs as compared to five of 18,869 inactive
siRNAs (0.03%). Importantly, analysis of the Eg5 inhibitor override screen11, as well as the
homologous recombination screen13, failed to identify statistically overrepresented seed
sequences. In summary, GESS appears to be more sensitive in identifying potential off-
target effects compared to simple seed sequence analysis, and is furthermore capable of
directly identifying the sensitive transcript(s). Because GESS does not require that active
siRNAs contain a common seed sequence, it can detect off-target effects even if no
particular seed sequence is enriched among active siRNAs. GESS uses the sequence of an
mRNA transcript to “integrate” the information that is contained among different active
siRNAs.
In total, we have analyzed thirteen different screens (Supplementary Table 3), and identified
four screens, described here, in which statistically significant outliers were identified, and
for which microRNA-based off-targeting has been established as problematic. Nine
published RNAi screen datasets showed either no significant outliers or a few weakly
significant outliers whose biological significance has not been investigated. The sequences
of inactive siRNAs were not published for five of these nine screens, and thus we relied on
use of P1c-seed sequences as a source of inactive siRNAs. However, this approach is not as
information rich as using the experimentally determined inactive siRNAs, because the
statistical significance of enrichment in the GESS analysis depends not only on an increase
in the frequency of seed matches to a transcript among active siRNAs, but also a
corresponding decrease in frequency of seed matches among inactive siRNAs. Furthermore,
GESS analysis of genome-wide screens is most informative if siRNAs are screened
individually rather than as pools. Because screens in Drosophila and C. elegans utilize
multiple siRNAs generated from long dsRNAs (~500 base pairs), GESS is unlikely to be
informative in these systems.
Why some transcripts are particularly sensitive to miRNA-like off-targeting remains
unclear. MAD2 is average among known spindle checkpoint in terms of 3′UTR length or
AU-richness, ruling out trivial explanations. The MAD2 3′UTR may contain specific
secondary structures or bind to specific proteins that render it particularly sensitive to off-
target effects. Alternatively, the SAC may be particularly sensitive to small changes in
MAD2 protein levels. Consistent with this idea, MAD2 is a haplo-insufficient tumor
suppressor in vivo, and cells lacking one copy of MAD2 show decreased ability to arrest in
mitosis in the presence of microtubule inhibitors15. Similarly, the process of homologous
recombination may be particularly sensitive to RAD51 gene dosage, explaining why RAD51
was identified by GESS as a prominent off-target in an siRNA screen for genes involved in
homologous recombination13. Finally, similar observations were reported for the TGFβ
pathway RNAi screen9 where minor reductions of the TGFβ receptor transcripts appear to
have major effect on the screen assay. Together these findings suggest it may be useful to
assemble a database of genes whose transcripts are highly sensitive to off-target effects, and
incorporate this information into the design algorithms used to generate siRNAs.
Incorporation of GESS as a routine component of the analysis of high-throughput screens
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tshould enable investigators to counter-screen for downregulation of sensitive transcripts and
reduce the false positive rate during the validation process. Identification of transcripts
sensitive to off targeting will also enable a better understanding of the rules that govern
miRNA-like targeting and help further improve the design of siRNA reagents for future
RNAi screens.
METHODS
The GESS standalone package used in this manuscript is provided as a compressed archive
(Supplementary Software 1–5). Software packages for updated versions will be available on
our website (http://king.med.harvard.edu/). All siRNA sequences and associated phenotype
data used to perform GESS analyses described in this manuscript are provided as a
compressed archive (Supplementary Data 1). Excel result files for the main GESS analyses
in this manuscript are provided as a compressed archive (Supplementary Data 2). Transcript
database files for the human and mouse genomes are available as a compressed archive
(Supplementary Data 3). Methods and associated references are available in the online
version of the paper at http://www.nature.com/naturemethods/.
ONLINE METHODS
Tissue culture
HeLa H2B-GFP cells were grown from low passage in DMEM (Cell-Gro, Cat#10-013-CV)
supplemented with 10% Fetal Bovine Serum (FBS; Atlanta Biologicals Cat#S11150), in a
humidified incubator at 37°C and 5% CO2.
siRNA library
The Qiagen “Druggable” genome siRNA library V1.0, consisting of two individual siRNAs
for 5,090 human genes, was used in our primary siRNA screen. Non-targeting siRNA
control #3 (D-001210-01-20) and MAD2 (GGAACAACUGAAAGAUUGG-dTdT, custom
synthesis), were from Dharmacon. The sequences of all siRNAs used in this study are
reported in supplementary excel files along with corresponding phenotypic data.
siRNA transfections and image-based screening
HeLa H2B-GFP cells were plated at 1,000 cells per well in 30 µl OptiMEM containing 1%
FBS, supplemented with penicillin, streptomycin and 2 mM glutamine (pen/strep/glu) in
384-well plates (Corning, #3712), 16–18 hrs prior to transfection. The cells were washed
twice with OptiMEM containing pen/strep/glu, and then incubated in 40 µl OptiMEM pen/
strep/glu per well for 1–4 hrs prior to transfection. For each well to be transfected with
siRNA, 8 µl OptiMEM, 0.5 µl GTS diluent and 0.25 µl GeneSilencer (Genlantis) was first
premixed, and then added to 2 µM siRNA. The siRNA-reagent mix was incubated at room
temperature for 15 min and then added to cells, yielding a final siRNA concentration of 150
nM. Four-to-six hours post-transfection, 20 µl DMEM containing 30% FBS were added.
Taxol (150 nM final concentration) was added to the cells 32–36 hrs post-transfection.
Twenty-four hours later, cells were fixed and nuclei stained by adding one volume of DPBS
fix/stain solution (final concentrations: 3.7% Formaldehyde, 250 ng/ml Hoechst 33342
(Molecular Probes H-3570) and 0.1% Triton X-100). After 20 min incubation at room
temperature, the cells were washed 2–3 times with DPBS. Fluorescence images of nuclei
were obtained using a CellWoRx high-content screening microscope (Applied Biosystems).
Nuclear morphology was analyzed by manual inspection of images. Untransfected cells and
those transfected with control siRNA remain arrested in mitosis under these conditions
(Supplementary Fig. 1). In contrast, cells treated with a positive control siRNA targeting the
essential SAC component MAD2 exited mitosis, as indicated by the presence of interphase
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tcells with multilobed nuclei (SAC bypass; Supplementary Fig. 1). Each siRNA was
transfected in duplicate wells and each well was imaged in one location. Each image was
given a penetrance phenotype (P) reflecting the number of cells affected by the siRNA. The
penetrance categories were: 3 (80–100% cells affected), 2.5 (60–80% cells), 2 (40–60%
cells), 1.5 (15–40% cells) and 1 (>0% to 15% cells). A sub-rating (SR), reflecting the
proportion of affected cells showing SAC bypass, was also assigned using similar categories
from 3 to 1. The penetrance and sub-rating category values were multiplied to reflect the
overall rate of bypass in each image and the higher rate of the two replicates per siRNA was
retained. Three phenotype thresholds were considered in the present analyses: a high
threshold (P × SR = 9), yielding 49 active siRNAs; a relaxed threshold (P × SR ≥ 7.5),
yielding 137 siRNAs; and a low threshold (P × SR ≥ 2), yielding 324 active siRNAs.
Plasmid constructs
Total RNA was isolated and purified from HeLa H2B-GFP cells using the RNeasy kit
(Qiagen Cat# 74104). A cDNA library was generated by reverse transcribing the total RNAs
using a reverse transcription system (Promega, A3500) following manufacturer’s protocol.
MAD2 mRNA sequences were PCR amplified from the cDNA library. The PCR primers
contained XbaI sites at both extremities. XbaI digested PCR fragments were cloned into the
pGL3-control vector (Clontech) digested with XbaI. This results in expression of an mRNA
coding for the Firefly luciferase with MAD2 sequences downstream of the stop codon. The
BglII-BamHI cassette from pRL-TK vector (Clontech), containing the Renilla Luciferase
gene under the control of HSV Thymidine kinase promoter, was non-directionally cloned
into the BamHI site of the pGL3-control and pGL3-control-*-MAD2 sequences vectors.
Resulting plasmids sequences were verified by DNA sequencing.
Luciferase reporter assays
HeLa H2B-GFP cells were plated in 24-well plates (BD Falcon 353047) at 30,000 cells per
well in 500 µl OptiMEM containing 1% FBS and pen/strep/glu. Sixteen hours after plating,
cells were transfected with 50nM siRNAs with GeneSilencer as follows. The cells were
washed with OptiMEM and then incubated 1–4 hrs in 150 µl OptiMEM + pen/strep/glu in
the absence of FBS. GTS diluent (2.5 µl) and 1.25 µl GeneSilencer reagent were premixed in
40 µl OptiMEM and added to 5 µl of siRNA stocks (2 µM) for each well. The siRNA
transfection mix was incubated 15 min at room temperature and added to the cells. DMEM
containing 20% FBS (200 µl) was added to each well 4–6 hrs after siRNA transfection.
Twenty-four hours later, the siRNA transfection medium was replaced with 500 µl growth
medium (without pen/strep/glu) and plasmid transfection was initiated. Plasmids (500 ng per
well) were transfected with Fugene 6 (Roche) using a reagent ratio of 5 µl Fugene 6: 2 µg
plasmid. OptiMEM (100 µl) was mixed with 0.75 µl Fugene 6 and pre-incubated at room
temperature for 5 min. The pre-mix was added to 500 ng plasmid. The plasmid-reagent mix
was then added to the cells after 15 min incubation at room temperature. Dual luciferase
assays were performed 24–48 hrs after initiating plasmid transfections, following the
manufacturer’s protocol (Dual-Glo system, Promega). Luminescence measurements were
performed on an Envision plate reader (Perkin Elmer).
Branched DNA (bDNA) assay for mRNA level quantification
Messenger RNA levels were measured, in duplicate, 48 hrs after siRNA transfection of
20,000 HeLa H2B-GFP cells per well in 24-well plates (as described for the luciferase
assays). The bDNA assay (QuantiGene / Panomics) was conducted following the
manufacturer’s protocol and using probe sets specific to MAD2 (PA-11305-02;
NM_002358), BUBR1 (PA-11159-01; NM_001211), BUB1 (PA-11577-01; NM_004336),
or the housekeeping genes GAPDH (PA-10382-02; NM_002046) and PPIB/Cyclophilin
(PA-10384-02; NM_000942). Duplicate measurements were averaged, normalized per
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taverage housekeeping PPIB mRNA measurement. The normalized ratio for control siRNA
transfected cells was used as 100% reference for determination of relative changes in the
ratio for other siRNAs. The results were displayed as a heat map with indicated scale using
Spotfire DecisionSite.
Quantitative Western blotting
MAD2 and GAPDH protein levels were determined by SDS-PAGE separation of proteins
followed by Western blotting. The proteins were detected using a rabbit anti-MAD2 (Bethyl,
A300-301A) and mouse anti-GAPDH (AbCam, ab8245) antibodies. Secondary antibodies
coupled to fluorophores (anti-mouse Alexa-Fluor750 and anti-rabbit Alexa-Fluor680,
Invitrogen) were used to detect both signal on the same membrane using an Odyssey (Li-
Cor Biosciences) scanner. Quantifications were performed using the Odyssey program and
are reported as MAD2/GAPDH signal ratio, normalized to control treatment.
Sequence databases
Genome-wide sequences for human 5′UTRs, coding sequences or 3′UTRs were retrieved
from the Ensembl database using the online tool Martview (www.biomart.org; Ensembl
Genes 61, Human genome built GRCh37 or earlier) or Refseq using the UCSC Genome
Bioinformatics table browser (http://genome.ucsc.edu/cgi-bin/hgTables; Refseq 44).
Sequences of 19 nucleotides or less and duplicate sequences were removed and the
remaining sequences were formatted into a text file with one sequence per line and
corresponding identity information was formatted into an excel file with the same name
(Supplementary Data 3).
Genome-wide Enrichment of Seed Sequences (GESS) bioinformatics tool
MATLAB 2007 and more recent versions were used to program and run the GESS seed
match search tool. The program is provided as MATLAB m-code files and as standalone
versions packaged with the appropriate MATLAB Compiler Runtime (MCR) for Windows
32 and 64bit, Linux 32 and 64bit and Mac OS (Supplementary Software 1–5). The packages
were compiled using MATLAB Compiler version 4.14 or later. Input data files consist of
two text files that can be generated following the GESS manual provided along with the
program. One contains a list of either all 19 nucleotide siRNA sequences (sense strand
sequence or target sequence) in upper case with ATGC code (no U) one sequence per line,
or only the sequence of active siRNAs if inactive siRNA sequences are unavailable. The
second file contains phenotypic data (1 for siRNA with phenotype, 0 for siRNA with no
phenotype) in the same order as the siRNA sequences, one number per line when providing
both active and inactive siRNA sequences. If only active siRNA sequences are provided,
GESS generates control siRNA seed sequences by changing nucleotide 1 of each seed to its
complement and no phenotypic data file is required. To run a GESS methodology negative
control run, siRNA seed sequences of both active and inactive siRNAs can optionally be
randomly scrambled by the program. The program requests the user to define the length of
seed sequences to analyze (typically 6 to 8 nucleotides with the default being 7) and the
minimal number of seed matches (multiplicity) an siRNA must show towards a target
sequence in order to consider it matching. The program allows selection of the strand(s) of
the siRNA that should be used in the analysis. Either strand is considered by default,
meaning that a seed sequence derived from either the sense or antisense strand must contain
a seed match to the target sequence for the siRNA to be considered matching. Alternatively,
the antisense strand only, the sense strand only or both strands (each strand must satisfy the
seed matching parameters) can be analyzed. The program also asks the user to indicate
which genome-wide transcript sequence database text file should be used (3′UTR, 5′UTR
and CDS sequence databases for human and mouse are provided as Supplementary Data 3).
The transcript sequences must be in upper case, one sequence per line with ATGC code (no
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tU). Three different multiple hypotheses testing correction methods can be selected in the
analysis, as below. If a significant outlier is detected in the primary GESS run, the analysis
can be repeated after removing the major outlier, as this approach might enable other, less
prominent off-target effects to be detected. The user simply chooses the option to exclude
siRNAs matching a sequence and provides a text file containing the outlier sequence.
Statistical analysis of GESS results
Because some of the sequences analyzed contained low seed match event numbers, we
calculated the Chi square with correction for continuity (Yates’ Chi square) statistics which
compensates for low event numbers.
N: total number of siRNAs tested in the GESS analysis.
NsiPhen: number of siRNAs with phenotype.
NsiNoPhen: number of siRNAs with no phenotype.
NsiPhenMatch: number of siRNAs with phenotype with seed matching to tested sequence.
NsiNoPhenMatch: number of siRNAs with no phenotype with seed matching to tested
sequence.
NsiMatch: number of siRNAs with seed matching to tested sequence.
NsiNoMatch: number of siRNAs with no seed matching to tested sequence.
NsiPhenNoMatch: number of siRNAs with phenotype with no seed matching to tested
sequence.
NsiNoPhenNoMatch: number of siRNAs with no phenotype with no seed matching to tested
sequence.
The one-tailed probability (P value) of the Yates’ Chi square statistics was calculated (with a
degree of freedom of one). The Chi Square was set to zero if the Chi Square calculation
denominator was null (the Yates’ Chi square cannot be calculated). The corresponding P
value is then equal to one. If any of NsiPhenMatch, NsiPhenNoMatch, NsiNoPhenMatch,
NsiNoPhenNoMatch was less than or equal to 20, the Fisher’s exact test two-sided P value was
determined instead of the Yates’s Chi Square P value. The genomic sequences were ranked
from the one with lowest P value (rank = 1) to the one with highest P value (rank = A, the
number of genomic sequences analyzed).
Three multiple hypotheses testing correction methods have been implemented in GESS. The
Benjamini and Hochberg False Discovery Rate correction16 (Simes’ method) was used as
default as it is considered a good balance between limiting report of false positive and false
negative off-target transcripts. The null hypothesis (there is no difference between the
frequency of siPhen and siNoPhen containing a seed match to a given sequence) was
rejected if the P value calculated above was less than the corrected P value threshold
(α×rank of sequence / A) where α is set as 0.05 by default (more stringent α values can be
input by the user) and A is the number of genomic sequences analyzed. The number of
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tsequences passing or failing the test is indicated on each graph. Two additional methods are
available for analysis by the user, namely, the Bonferroni17 and the Bonferroni step-down18
(Holm) methods. The corrected P value thresholds are (α / A) and (α / (A + 1 – rank of
sequence)), respectively. These methods are more stringent than the Benjamini and
Hochberg method. While they can be used to limit the rate of false positive off-targets
identified, weaker genuine off-targets may be missed as false-negatives in the analysis.
Corrected P value thresholds and associated statistical significance status for the three
methods are reported in the GESS_Results file.
Data visualization
The program plots the percentage of siRNAs containing a seed match to a transcript of
interest, comparing the siRNAs with phenotype (Y-axis) to those without phenotype (X-
axis). Each genomic sequence is represented by one point on the graph and statistical
enrichment of significance is indicated in red. Alternatively, Spotfire DecisionSite was used
to generate the graphs. Sequences with statistically significant seed match enrichment were
depicted in red while non-significant sequences were depicted in gray. The numbers of
significant and non-significant outliers are provided.
siRNA seed sequence enrichment analysis (SSEA)
The GESS algorithm was adapted to be applied to siRNA seed sequences as follows. A list
of 16,384 7mer seed sequences was generated and stored as a text file and excel file in the
same format as the transcript sequences database files. These text files were used instead of
the genome-wide transcript sequence databases to search for seed presence in the active and
inactive siRNAs. All calculations and statistical decisions were performed similarly as for
the GESS method. Provided fewer events are expected to be counted as compared to a
GESS analysis, the multiple hypothesis testing error correction was restricted to the
Benjamini and Hochberg method.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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tFigure 1. Summary of the Genome-wide Enrichment for Seed Sequence matches (GESS) method
The GESS algorithm begins by splitting the set of siRNAs into two sets: those with
phenotype and those without phenotype. The user enters criteria for defining a matching
transcript, including the siRNA strand(s), seed length (J) and seed match multiplicity (K).
GESS calculates the percent of siRNAs in each set that shows seed matching with each
sequence in the genome-wide database (SMFa for active siRNAs and SMFi for inactive
siRNAs). Statistical significance of seed match enrichment (SME) among the set of active
siRNAs compared to the set of inactive siRNAs is performed (see Methods).
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tFigure 2. GESS identifies major off-targeted transcripts in RNAi screen datasets
(a) The plot shows GESS analysis of 27,534 human mRNA 3′UTRs on the primary data
from a screen that identified siRNAs inducing loss of SAC function. Each point represents
one 3’ UTR, and indicates the percentage of active siRNAs containing a seed match to the 3’
UTR (SMFa; percent of n = 49 total active siRNAs) plotted against the percentage of
inactive siRNAs containing a seed match to the 3’ UTR (SMFi; percent of n = 9,856 total
inactive siRNAs). (b) The plot shows GESS analysis as above on data published from an
siRNA screen for components required for mitotic arrest upon inhibition of the mitotic
kinesin Eg5 in HeLa cells11. P1c-seeds were used as the source of inactive siRNAs (n = 308,
Sigoillot et al. Page 12
Nat Methods. Author manuscript; available in PMC 2012 October 28.
N
I
H
-
P
A
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
t
N
I
H
-
P
A
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
t
N
I
H
-
P
A
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
tfor both active and inactive siRNAs). (c) The plot shows GESS analysis as above, on data
published from an siRNA screen for genes involved in the TGFβ pathway9. Experimentally
identified siRNAs that showed no phenotype (a cutoff of two standard deviations of activity
was used to separate active from inactive siRNAs) were used for the set of inactive siRNAs
(n = 391 active siRNAs, n = 18,869 inactive siRNAs). Significance threshold was
determined independently for each data point, using the Benjamini and Hochberg (Simes’)
method to correct the baseline value of α which is 0.05. Statistically significant outliers are
depicted in red and their number is reported.
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tFigure 3. GESS-informed selection of siRNA pools enriches for genes that reproduce the
primary phenotype upon targeting with additional siRNAs
The schematic shows that siRNA pools targeting 641 transcripts scored in a primary screen
for genes required for homologous recombination. Upon deconvolution, pools targeting 99
genes showed the phenotype on at least two out of four siRNAs. Of these genes, 88 were
further evaluated (11 genes were dropped because no additional siRNAs were commercially
available, the original pool showed toxicity, or the retested genes were in the lower spectrum
of primary screen scores). GESS analysis showed that the RAD51 3′UTR is sensitive to off-
targeting. The schematic shows the rate at which the phenotype was reproduced with and
without removal of siRNAs that contain a 7mer seed match to RAD51 3′UTR.
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